OTCM
SHMXY
Market cap7.73bUSD
Jun 10, Last price
12.20USD
Name
Shimadzu Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Shimadzu Corporation, established in Kyoto, Japan, in 1875, is a global enterprise recognized for its extensive range of cutting-edge instruments and machinery. The company's primary business activities are segmented across several key technological domains. Its analytical and measuring instrument division offers a comprehensive suite of products. This includes various chromatography and mass spectrometry systems (both gas and liquid), advanced tools for molecular and elemental analysis, surface analysis equipment, and essential instruments for life science laboratories. Additionally, they provide solutions for total organic carbon analysis, continuous process monitoring, thermal and particle size analysis, materials testing and inspection, non-destructive testing, and precision balances, all integrated with robust data management and software. In the medical systems sector, Shimadzu delivers state-of-the-art diagnostic imaging technologies. Their offerings span angiography and fluoroscopy systems, mobile C-arms, various radiography and X-ray systems (including mobile units), and fluorescence imaging products. Beyond medical, the company also manufactures high-precision optical and vacuum components, such as diffraction gratings, aspherical mirrors, laser mirrors, polka-dot beam splitters, and precision refractometers, alongside industrial vacuum equipment like turbo molecular pumps, helium leak detectors, sputtering and multi-deposition systems, and vacuum heat-treatment furnaces. Shimadzu's industrial machinery portfolio is diverse, featuring liquid delivery gear pumps, mechatronic systems like glass fiber winders and liquid crystal injection systems, and dynamic balancing machines. They also supply specialized hydraulic equipment, including hydraulic gear pumps, power packages, and multi-control valves. Lastly, the company contributes to the aerospace industry by producing critical aircraft equipment, such as electro-mechanical actuators, sophisticated flight control systems, and landing gear systems.
Key people
Yasunori Yamamoto
President, Chief Executive Officer, Executive Officer, Representative Director · since 2022
Takahiro Nishimoto
Managing Executive Officer, Chief Technology Officer · since 2025
Koki Aoyama
Senior Managing Executive Officer · since 2025
Katsuaki Kaito
Senior Managing Executive Officer · since 2023
Shigenori Aoyama
Managing Executive Officer, Chief Human Resources Officer · since 2025
Komei Arakane
Managing Executive Officer, Chief Financial Officer · since 2025
Yoshino Kajitani
Managing Executive Officer · since 2021
Yoshiaki Maeda
Managing Executive Officer · since 2025
Shunei Matoba
Managing Executive Officer, Chief Director of Sales, President of Tokyo Office · since 2024
Kiyohito Sonoki
Managing Executive Officer, Director of Medical Equipment Business · since 2023
Masami Tomita
Managing Executive Officer, Director of Analysis and Measurement Business · since 2023
Masahiko Tanaka
Senior Executive Officer, Director of Industrial Machinery Business, Director of Fluidics Business · since 2025
Shigeki Morimoto
Executive Officer, Deputy Chief Director of Sales, Manager of Sales Promotion Unit · since 2024
Kaoru Ihara
Executive Officer, Director of Human Resources · since 2024
Palanisamy Anand
Executive Officer, President of Subsidiary · since 2023
Patrick Formal
Executive Officer, President of Subsidiary · since 2025
Yoshiaki Hirao
Executive Officer, President of Subsidiary · since 2023
Takeaki Inoue
Executive Officer, Deputy Director of Business in Analytical and Measuring Unit · since 2025
Takashi Inoue
Executive Officer, Deputy Director of Business in Analysis and Measurement Unit · since 2025
Gaku Ishii
Executive Officer, Deputy Director of Business in Aviation Equipment Unit · since 2025
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||